NCT04039490 Novel Device for Ultrasound-guided Pediatric Vessel Cannulations
| NCT ID | NCT04039490 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Clear Guide Medical |
| Condition | Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-02-06 |
| Primary Completion | 2025-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-02-06 with a primary completion date of 2025-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Clinical Trial to investigate whether the use of a novel device to be used in conjunction with ultrasound in pediatric vessel cannulations is superior to ultrasound-only pediatric vessel cannulations in terms of number of cannulation attempts.
Eligibility Criteria
Inclusion Criteria: * any pediatric patient scheduled for a vessel cannulation at CNMC Exclusion Criteria: * none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04039490 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 17 Years, studying Clinical Procedures Which Require Vessel Cannulations in Pediatric Patients. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04039490 currently recruiting?
Yes, NCT04039490 is actively recruiting participants. Contact the research team at heisenberg@clearguidemedical.com for enrollment information.
Where is the NCT04039490 trial being conducted?
This trial is being conducted at Washington D.C., United States.
Who is sponsoring the NCT04039490 clinical trial?
NCT04039490 is sponsored by Clear Guide Medical. The trial plans to enroll 60 participants.